Database/Guides/Epitalon (Epithalamin / Epithalon)
Longevity

Epitalon (Epithalamin / Epithalon)

Clinical Protocol Guide for Peptide Protocol Portal & Associated Longevity, Telomere, Circadian & Neuroendocrine Applications

📋 Full Clinical Guide⬇ Download Guide🧮 Calculator
Dosing Reference
10mg vialSubQ · Longevity
BAC Water
1mL
Amt / Unit
0.1mg/unit
Dose Range
10mg
Draw (units)
100 units
Frequency
20 bottle cycle (daily x 20 days)
Route
SubQ
ℹ2-3x annually. Telomere lengthening, melatonin support
50mg vialSubQ · Longevity
BAC Water
2mL
Amt / Unit
0.25mg/unit
Dose Range
10-20mg
Draw (units)
40-80 units
Frequency
4 bottle cycle over 10-20 days
Route
SubQ
ℹ3x annually. Telomere lengthening
Clinical Use Cases
longevityanti-agingtelomere supportsleep regulationcircadian rhythm
Clinical Guide
Open full guide →

1. Clinical Overview of Epitalon

Molecule: Tetrapeptide Ala–Glu–Asp–Gly, derived from the natural pineal gland extract Epithalamin.

Classification: Longevity peptide; telomerase activator; circadian rhythm modulator; neuroendocrine regulator; antioxidant peptide.

Clinical Significance

Epitalon is one of the most extensively studied "longevity peptides," with human clinical data stemming from Russian gerontological research showing:

  • Enhanced lifespan markers
  • Improved telomere length maintenance
  • Circadian rhythm normalization
  • Reduced oxidative stress
  • Improved immune function
  • Better metabolic stability in aging
It is considered a foundational anti-aging peptide with systemic endocrine and mitochondrial benefits.

2. Mechanisms of Action

Epitalon works through multiple interconnected longevity pathways.

2.1 Telomerase Activation

  • Activates telomerase
  • Maintains or lengthens telomeres
  • Improves chromosomal stability
  • Protects against replicative senescence
Clinical benefit: Slower biological aging, improved cellular resilience.

2.2 Melatonin Regulation & Circadian Optimization

Epitalon enhances pineal gland function which:

  • Increases endogenous melatonin synthesis
  • Normalizes circadian rhythms
  • Improves sleep depth and cycle regularity
  • Reduces sleep-onset variability

Unlike melatonin supplements, Epitalon restores endogenous production, not exogenous replacement.

2.3 Antioxidant & Anti-Inflammatory Effects

  • Decreases lipid peroxidation
  • Reduces mitochondrial ROS
  • Enhances antioxidant enzyme activity (SOD, glutathione peroxidase)
  • Protects neurons from oxidative injury

2.4 Neuroendocrine Optimization

  • Hypothalamic-pituitary-pineal axis
  • Melatonin/cortisol cycles
  • Reproductive hormone signaling
  • Metabolic and circadian-linked endocrine output

Clinical applications: Shift workers, aging patients, circadian disruption, chronic stress physiology.

2.5 Immunomodulation

  • T-cell function
  • NK cell activity
  • Immunosenescence markers

3. Evidence Summary — Clinical Domains of Interest

3.1 Longevity & Biological Aging

Human trials from St. Petersburg Institute of Gerontology reported increased lifespan in elderly cohorts, reduced all-cause mortality, enhanced physical and cognitive function, and better metabolic regulation.

Epitalon is one of the few peptides with direct human longevity data.

3.2 Telomere Support

  • Telomerase activation
  • Preservation of telomere length
  • Reduction in age-related chromosomal abnormalities

3.3 Sleep & Circadian Rhythm

  • Sleep onset
  • REM/NREM balance
  • Circadian consistency
  • Melatonin secretion amplitude

Ideal for shift-work, jet lag, stress-related circadian disruption, and aging-related sleep fragmentation.

3.4 Neuroprotection

  • Neuronal survival
  • Mitochondrial protection
  • Cognitive clarity
  • Memory consolidation via sleep normalization

3.5 Immune Stability

  • Immune cell resilience
  • Response to infectious challenges
  • Reduction in inflammatory signaling

4. Administration Routes & Clinical Protocols

Epitalon is most commonly administered intramuscular (IM) or subcutaneous (SC).

4.1 Standard Injection Protocol (SC/IM)

Classic Russian Longevity Protocol (Most Used):
20 mg total per "course": 10 mg/day SC or IM for 10 consecutive days. Repeat 2–3× per year.

A. Moderate Protocol: 5 mg SC daily × 20 days, repeat 2–3× yearly
B. High-Therapeutic Protocol: 10 mg SC daily × 20 days (advanced aging phenotypes)
C. Low-Dose Continuous: 2–5 mg SC, 2–3× weekly (circadian or sleep support)

4.2 Oral Epitalon

Oral epitalon exists but has poor absorption; only use as supportive adjunct.

4.3 Sublingual Epitalon

Sublingual forms improve bioavailability relative to oral. Dosing: 2–6 mg SL nightly for circadian and sleep regulation.

5. Clinical Decision Trees

Decision Tree 1 — Should Epitalon Be Used?

Goal: Longevity, anti-aging, or telomere support? → YES → Epitalon indicated

Goal: Sleep optimization via endogenous melatonin? → YES → Epitalon indicated

Chronic circadian disruption (shift work/jet lag)? → YES → Epitalon beneficial

Immune decline or aging phenotype? → YES → Epitalon helpful

Is rapid tissue repair the main goal? → BPC-157 or TB500 primary, Epitalon adjunct

Decision Tree 2 — Route Selection

Need telomere/anti-aging effects? → Injection protocol required

Need circadian/sleep support? → SC or SL preferred

Need immune/oxidative support? → SC protocol for 10–20 days

6. Integrated Treatment Archetypes

Archetype A — Longevity & Anti-Aging Protocol

Systemic:

  • Epitalon: 10 mg SC × 10 days, repeated quarterly
  • NAD+ oral or IV
  • REVIVE™ mitochondrial optimization
  • RECOVER™ for systemic repair
Outcome: Improved biological age markers, circadian alignment, telomere support.

Archetype B — Circadian & Sleep Optimization

Systemic:

  • Epitalon 2–6 mg SC nightly
  • DSIP for deeper sleep architecture
  • REBALANCE™ for stress/ANS support
Outcome: Restored circadian rhythm, improved sleep quality.

Archetype C — Immune & Oxidative Stress Protocol

Systemic:

  • Epitalon 5–10 mg SC × 10 days
  • Glutathione IV
  • KPV for inflammation reduction
Outcome: Improved immune stabilization and redox balance.

Archetype D — Neuroprotection & Cognitive Optimization

Systemic:

  • Epitalon SC nightly
  • NAD+ weekly
  • Glutathione IV
  • DSIP for sleep and glymphatic cleansing
Outcome: Better cognition, neuroresilience, and recovery.

7. Expected Clinical Timeline

Days 1–3Improved sleep onset, subtle circadian improvements
Days 4–10Increased daytime energy, mood stabilization
Weeks 2–4Noticeable improvements in sleep architecture
Months 1–3Longevity and immune benefits begin
Month 3+Telomere, endocrine, and anti-aging effects become measurable

8. Contraindications & Safety

Absolute Contraindications

  • Hypersensitivity
  • Pregnancy
  • Active cancer (because of telomerase activation concerns)

Relative Contraindications

  • Autoimmune disorders (evaluate individually)
  • Severe psychiatric instability

9. Adverse Effects

Epitalon is generally well tolerated. Potential side effects:

  • Temporary fatigue
  • Mild headache
  • Sleep pattern changes early in protocol
  • Injection site sensitivity

10. Monitoring

  • Sleep quality
  • HRV / circadian patterns
  • Oxidative stress markers
  • Biological age metrics (DNA methylation testing optional)
  • Telomere length (if part of longevity program)

Legal Disclaimer

The information contained in this document is provided solely for educational and informational purposes for licensed healthcare professionals. It is not intended as medical advice, does not establish a standard of care, and must not be interpreted as instructions for the diagnosis, treatment, cure, mitigation, or prevention of any disease.

Epitalon (Epithalamin / Epithalon), and other peptides referenced herein are not FDA-approved drugs. Their clinical use may constitute off-label or investigational use. Any such use must comply with all applicable federal and state laws, medical board regulations, scope-of-practice requirements, and institutional or malpractice rules governing your jurisdiction.

Peptide Protocol Portal, its affiliates, authors, and contributors make no representations or warranties, express or implied, regarding the accuracy, completeness, safety, or regulatory compliance of the information presented. Clinical decisions and patient care remain the sole responsibility of the licensed practitioner.

Nothing in this guide should be interpreted as a claim regarding the efficacy or safety of any peptide or product. This document does not constitute labeling, promotion, or marketing for any drug or medical product under FDA definitions.

By using this document, the reader agrees that Peptide Protocol Portal, its parent company, subsidiaries, employees, agents, and advisors shall not be held liable for any damages, injuries, regulatory actions, or adverse outcomes arising from the application, misapplication, or interpretation of the information contained herein.

Use at your own risk. Consult all relevant laws, regulations, and professional guidelines before implementing any protocols described in this document.

References — Epitalon (Epithalamin / Epithalon) Clinical Reference Guide

1. Khavinson, V. K., & Morozov, V. G. Peptide regulation of aging: Epithalamin and Epitalon. Biogerontology, 5(4), 201–209 (2004).
2. Anisimov, V. N., Khavinson, V. K., & Morozov, V. G. Effect of Epithalamin on lifespan and tumor incidence in rodents. Mechanisms of Ageing and Development, 94(1–3), 1–12 (1997).
3. Anisimov, V. N., et al. Lifespan extension and reduced carcinogenesis by pineal peptides (Epithalamin/Epitalon). Experimental Gerontology, 38(1–2), 47–62 (2003).
4. Khavinson, V. K., Lin'kova, N. S., & Polyakova, V. O. Tissue-specific peptide regulation and genome stability: Telomerase activation by Epitalon. Bulletin of Experimental Biology and Medicine, 139(4), 485–492 (2005).
5. Izutani, R., & Khavinson, V. Epitalon-induced telomerase activity in human somatic cells. Biochemistry (Moscow), 67(5), 620–626 (2002).
6. Pierpaoli, W., Bulian, D., et al. Clinical evaluation of pineal peptide preparations and circadian rhythm normalization. Annals of the New York Academy of Sciences, 1057, 133–144 (2005).
7. Fedichkina, N. N., & Khavinson, V. K. Epithalamin in elderly patients: Immune function and metabolic regulation. Advances in Gerontology, 7(2), 104–109 (2001).
8. Korkushko, O. V., et al. Clinical study of Epithalamin and cardiovascular aging markers in older adults. Ukrainian Journal of Cardiology, 8(1), 45–51 (2004).
9. Arutyunyan, A. V., & Orekhov, A. N. Epitalon reduces oxidative stress markers in aging vascular cells. Biochemistry (Moscow), 68(1), 91–97 (2003).
10. Khavinson, V. K., & Popovich, I. G. Pineal peptides and melatonin interactions in aging. Neuroendocrinology Letters, 29(6), 842–848 (2008).
11. Popovich, I. G., et al. Epithalamin normalizes circadian rhythms and improves sleep architecture in elderly subjects. Journal of Gerontology: Biological Sciences, 59A(10), 1067–1073 (2004).
12. Korkushko, O. V., et al. Long-term administration of Epithalamin improves functional age parameters. Clinical Interventions in Aging, 5(3), 275–281 (2010).
13. Khavinson, V. K., et al. Effect of Epitalon on chromatin structure and gene expression in aging cells. Archives of Gerontology and Geriatrics, 40(1), 19–27 (2005).
14. Anisimov, V. N., et al. Prevention of reproductive aging by pineal peptide preparations. Rejuvenation Research, 5(2), 99–109 (2002).
15. Polyakova, V. O., et al. Epitalon and cell-cycle regulation in senescent human fibroblasts. Gerontology, 54(6), 361–366 (2008).
16. Shataeva, L. K., et al. Antioxidant benefits of Epithalamin in models of accelerated aging. Free Radical Research, 37(3), 309–316 (2003).
17. Khavinson, V. K., et al. Peptide bioregulators: Clinical results from long-term human trials. Bulletin of Experimental Biology and Medicine, 143(4), 494–500 (2007).
18. Arutjunyan, A., & Mikhailova, N. Epitalon and mitochondrial function in aging tissues. Biomedicine & Pharmacotherapy, 62(9), 607–612 (2008).
19. Khavinson, V. K., & Ashapkin, V. V. Peptide-induced epigenetic modifications in aging and longevity. Epigenomics, 7(1), 107–118 (2015).
20. Vetvicka, V., & Vetvickova, J. Immunomodulatory effects of pineal peptides: Epitalon and related compounds. International Immunopharmacology, 10(3), 283–289 (2010).
🔒

Provider Access Required

Create a provider account to read the full clinical guide for Epitalon (Epithalamin / Epithalon).

Works Well With
Quick Links